相关实验视频

Updated: Jul 13, 2026

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time

Published on: August 26, 2009

"混合与匹配":自我分类组件控制的超分子聚合物纳米药物,用于促进联合化疗/光疗

Yanggui Wu¹, Ting Li², Zeke Li¹

¹Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, China.

Advanced materials (Deerfield Beach, Fla.)

|April 7, 2025

概括

这项研究开发了一种新型的自我分类超分子纳米配方,将化疗和光疗结合起来,以改善癌症治疗. 智能纳米医学,F/B/U@PHDO,精确地提供治疗剂,增强抗瘤疗效.

科学领域:

纳米医学是一种纳米医学.
超分子化学超分子化学
癌症治疗癌症治疗

背景情况:

精确的癌症纳米医学需要合理的分子控制治疗剂.
利用结构-属性-功能关系是有效纳米医学的关键.
当前的战略往往缺乏精确的空间控制和有针对性的交付.

研究的目的:

开发一种新的结超分子纳米配方,用于联合化疗/光疗 (CT/PT).
通过自选组装实现自主药物释放和增强抗瘤功效.
为了展示精确的纳米医学设计的新范式.

主要方法:

化学前药物 (FPtF) 和光疗药物 (BPeB) 的直角自分类组件,使用特定的结对 (二氨基 / 5 - 甲和汉密尔顿/巴比酸盐).
上转化纳米粒子 (UCNPs) 的封装用于近红外 (NIR) 光触发光疗法.
制造超分子聚合物纳米细胞 (F/B/U@PHDO).
通过pH/热刺激来控制药物释放的H-结合关联常数 (Ka) 的研究.

主要成果:

成功制造F/B/U@PHDO纳米细胞,具有精确的治疗剂的空间控制.
已证明可编程的H-结合解离和刺激响应药物释放.
通过结合CT/PT实现了增强的抗瘤疗效,验证了自我分类设计.

结论:

开发的H键超分子纳米配方为联合癌症治疗提供了精确有效的平台.
自排序组装为设计自主纳米药物提供了一个强大的策略.
这种方法代表了在癌症治疗中推进精密纳米医学的新范式.

关键词:

结合化疗/光疗疗法 -结合相互作用的相互作用.响应式货物释放自行分类组件组件智能超分子聚合物纳米医学

更多相关视频

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

Published on: November 14, 2015

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...